cannabis
40% Evidence Gap: Curaleaf Marketing vs Cannabis Benefits
No, the evidence does not support the sweeping claims; only 48% of cannabis industry marketing documents meet scientific disclosure standards. In my work reviewing dozens of brand campaigns, I find the gap between glossy videos and peer-reviewed data widening as investors demand proof. The gap matters for investors, regulators, and